You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Nociceptive opioid peptide receptors

Showing 1 - 25 of 7,993
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Alcohol Use Disorder Trial in Pittsburgh ([C-11], NOP-1A)

Completed
  • Alcohol Use Disorder
  • Pittsburgh, Pennsylvania
    University of PIttsburgh PET Facility
Jul 8, 2022

Cocaine Use Disorder Trial in Pittsburgh (Baseline [C-11]NPA PET Scan, d-amphetamine, Post-amphetamine [C-11]NPA PET Scan)

Recruiting
  • Cocaine Use Disorder
  • Baseline [C-11]NPA PET Scan
  • +2 more
  • Pittsburgh, Pennsylvania
    University of PIttsburgh
Jun 27, 2022

Cocaine Use Disorder Trial in Pittsburgh ([C-11], NOP-1A)

Completed
  • Cocaine Use Disorder
  • Pittsburgh, Pennsylvania
    University of Pittsburgh
Aug 2, 2019

Hip Arthropathy, Hip Disease Trial in Montauban (Dexmedetomidine, Sufentanil)

Recruiting
  • Hip Arthropathy
  • Hip Disease
  • Montauban, Tarn Et Garonne, France
    Edmundo Pereira de Souza Neto
Jul 6, 2022

Pain Trial in Leiden (Cebranopadol 600 µg, Cebranopadol 800 µg, Cebranopadol 1000 µg)

Recruiting
  • Pain
  • Cebranopadol 600 µg
  • +5 more
  • Leiden, Netherlands
  • +1 more
Aug 4, 2022

Opioid Use, Unspecified, Bariatric Surgery Candidate Trial in Athens (Opioid Free Anaesthesia, Opioid based anesthesia)

Recruiting
  • Opioid Use, Unspecified
  • Bariatric Surgery Candidate
  • Opioid Free Anaesthesia
  • Opioid based anesthesia
  • Athens, Greece
    G.Gennimatas General Hospital
Feb 21, 2023

Opioid Use Disorder, Back Pain, Stress Trial in Nashville (Placebo, Oxycodone, Naloxone)

Recruiting
  • Opioid Use Disorder
  • +2 more
  • Placebo
  • +2 more
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Mar 4, 2022

Hyperalgesia Trial in Orange (Remifentanil, Remifentanil+ Placebo, Remifentanil +ultra-low dose naloxone)

Recruiting
  • Hyperalgesia
  • Orange, California
    UC Irvine Medical Center
Nov 12, 2021

Hepatocellular Carcinoma, Transcatheter Arterial Chemoembolization, Pain Trial in Nanjing (Oxycodone, Sufentanil)

Recruiting
  • Hepatocellular Carcinoma
  • +3 more
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Sep 15, 2023

Alcohol Use Disorder Trial (Detoxification Program, PKAB, CFN)

Not yet recruiting
  • Alcohol Use Disorder
  • Detoxification Program
  • +2 more
  • (no location specified)
Jul 13, 2023

Cancer Pain Trial (Duloxetine 30 mg, Tramadol, Placebo)

Not yet recruiting
  • Cancer Pain
  • Duloxetine 30 mg
  • +2 more
  • (no location specified)
Apr 3, 2022

Surgical Procedure, Unspecified Trial in Copenhagen, Køge, Vejle (The NOL monitor (Pain Monitoring Device monitor-PMD200™))

Not yet recruiting
  • Surgical Procedure, Unspecified
  • The NOL monitor (Pain Monitoring Device monitor-PMD200™)
  • Copenhagen, Denmark
  • +3 more
Feb 9, 2023

Advanced Melanoma Trial in New Brunswick (Propranolol, Naltrexone)

Not yet recruiting
  • Advanced Melanoma
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Jul 18, 2023

Patients Treated With Different Modalities of Spinal Cord

Not yet recruiting
  • Spinal Cord Stimulation
  • +2 more
  • Implanted pulse generator for SCS with different programming modalities
  • Valencia, Spain
    Consorcio Hospital General Universitario
Jan 26, 2023

Pain, Acute, Pain, Postoperative, Pain, Chronic Post-Surgical Trial in Athens (Esmolol Hydrochloride, normal saline)

Recruiting
  • Pain, Acute
  • +6 more
  • Esmolol Hydrochloride
  • normal saline
  • Athens, Greece
    Evangelismos General Hospital
Oct 25, 2022

Opioid Use Disorder Trial (CVL-354, [11C]-LY2795050, [11C]-carfentanil)

Not yet recruiting
  • Opioid Use Disorder
  • New Haven, Connecticut
    New Haven, Connecticut
Jan 18, 2023

Metastatic Malignant Tumor in the Liver, Neuroendocrine Tumor Trial in San Francisco (procedure, biological, device)

Recruiting
  • Metastatic Malignant Neoplasm in the Liver
  • Neuroendocrine Neoplasm
  • Arterial Embolization
  • +3 more
  • San Francisco, California
    University of California, San Francisco
Dec 22, 2022

Pain Trial in Houston (anakinra, Placebo, Nociceptive pain challenge)

Recruiting
  • Pain
  • Houston, Texas
    The University of Texas Health Science Center at Houston
Jan 19, 2022

Cancer Pain, Adenocarcinoma Trial in Ottawa (Methadone, Morphine)

Withdrawn
  • Cancer Pain
  • Adenocarcinoma
  • (no location specified)
Dec 1, 2022

Chronic Pain, Chronic Pain Syndrome, Chronic Pancreatitis Trial in United States (Lacosamide)

Not yet recruiting
  • Chronic Pain
  • +9 more
  • Stanford, California
  • +4 more
Nov 9, 2022

Scoliosis Correction, Postoperative Analgesia, Esketamine Trial in Beijing (Esketamine, Dexmedetomidine, Sufentanil)

Active, not recruiting
  • Scoliosis Correction
  • +4 more
  • Beijing, Beijing, China
    Peking University First Hospital
Feb 7, 2023

Gastrointestinal Surgery Trial in XIan (sufentanil + nalbuphine, Sufentanil, hydromorphone + nalbuphine)

Completed
  • Gastrointestinal Surgery
  • sufentanil + nalbuphine
  • +2 more
  • XIan, Shanxi, China
    YANLI
Oct 11, 2022

Overlapping Pain Trajectory Study

Not yet recruiting
  • Migraine
  • +6 more
  • Conditioned Pain Modulation
  • +3 more
  • (no location specified)
Mar 2, 2023

The Association of Microbiome Patterns With Chronic Opioid Use

Recruiting
  • Chronic Pain
  • Opioid Use
    • La Jolla, California
      University of California San Diego
    Mar 30, 2022

    Oral Squamous Cell Carcinoma Trial in New York (Chemical sensitivity, Mechanical sensitivity)

    Recruiting
    • Oral Squamous Cell Carcinoma
    • Chemical sensitivity
    • Mechanical sensitivity
    • New York, New York
      New York University College of Dentistry
    Sep 26, 2022